Marc Tessier-Lavigne's Net Worth

$121 Million

Estimate Recalculated Nov 7, 2024 11:43AM EST

Who is Marc Tessier-Lavigne?

Marc Tessier-Lavigne has an estimated net worth of $121 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS, INC., PFIZER INC, AGIOS PHARMACEUTICALS INC, Denali Therapeutics Inc., Juno Therapeutics, Inc., and GENENTECH INC.

SEC CIK

Marc Tessier-Lavigne's CIK is 0001437435

Past Insider Trading and Trends

2021 was Marc Tessier-Lavigne's most active year for acquiring shares with 11 total transactions. Marc Tessier-Lavigne's most active month to acquire stocks was the month of December. 2021 was Marc Tessier-Lavigne's most active year for disposing of shares, totalling 42 transactions. Marc Tessier-Lavigne's most active month to dispose stocks was the month of August. 2022 saw Marc Tessier-Lavigne paying a total of $11,894,577.61 for 57,311 shares, this is the most they've acquired in one year. In 2020 Marc Tessier-Lavigne cashed out on 458,558 shares for a total of $24,611,206.99, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

REGENERON PHARMACEUTICALS, INC. (REGN) Snapshot price: $1131.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.27%
165
—
—
2.43K
Jan 3
Form 4
+7.27%
165
—
—
2.43K
Jan 3
Form 4
—
0
$557.79
-$3,131,173.50
2.27K
Scheduled
Sep 29 - Oct 3
Form 4
—
0
$535.48
-$2,299,022.95
2.27K
Scheduled
Mar 21
Form 4
—
0
$526.99
-$3,687,054.98
2.27K
Scheduled
Mar 16 - Mar 17
Form 4
+9.19%
191
—
—
2.27K
Jan 3
Form 4
—
0
$518.20
-$1,110,982.40
2.08K
Scheduled
Dec 9
Form 4
—
0
$457.69
-$4,692,534.31
2.08K
Scheduled
Sep 13
Form 4
+13.55%
248
—
—
2.08K
Jan 4
Form 4
—
0
$370.90
-$5,792,196.00
1.83K
May 6
Form 4
—
0
$226.55
-$4,953,767.10
1.83K
Feb 13
Form 4
+21.19%
320
—
—
1.83K
Jan 2
Form 4
+27.21%
323
—
—
1.51K
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
$323.69
-$2,665,725.00
1.19K
Aug 5
Form 4
—
0
$236.43
-$1,113,134.00
1.19K
Feb 26
Form 4
—
0
—
—
0
Jan 2
Form 4
∞
1.19K
$201.54
-$903,581.83
1.19K
Aug 26 - Aug 27
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$157.07
-$2,769,107.86
0
May 6
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Nov 18
Form 3
—
0
—
—
0
No matching records found

PFIZER INC (PFE) Snapshot price: $28.5196

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 23
Form 4
—
0
—
—
0
Apr 24
Form 4
—
0
—
—
0
Apr 25
Form 4
—
0
—
—
0
Apr 26
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Dec 12
Form 3
—
0
—
—
0
No matching records found

AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $43.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
May 30
Form 4
+122.22%
55.55K
$18.00
$999,990.00
101.01K
Jul 24
Form 4
—
0
—
—
0
Dec 4
Form 3
—
0
—
—
0
No matching records found

Denali Therapeutics Inc. (DNLI) Snapshot price: $25.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.32%
5.97K
—
—
1.88M
May 31
Form 4
+0.23%
4.22K
—
—
1.87M
Jun 1
Form 4
-1.06%
-20.00K
$30.48
-$609,600.00
1.87M
Scheduled
Nov 23
Form 4
-1.05%
-20.00K
$30.27
-$605,462.76
1.89M
Scheduled
Nov 1 - Nov 2
Form 4
-1.04%
-20.00K
$30.82
-$616,303.82
1.91M
Scheduled
Sep 28
Form 4
-1.03%
-20.00K
$31.61
-$632,282.00
1.93M
Scheduled
Aug 23
Form 4
-1.02%
-20.00K
$35.61
-$712,110.00
1.95M
Jul 25
Form 4/A
-0.98%
-20.00K
$33.83
-$676,582.52
2.02M
Mar 23
Form 4
-2.96%
-60.00K
$30.72
-$1,843,044.74
1.97M
Jun 23 - Jun 24
Form 4
+0.30%
5.99K
—
—
2.03M
Jun 2
Form 4
-0.98%
-20.00K
$33.83
-$676,582.52
2.02M
Mar 23
Form 4
-2.48%
-63.13K
$44.44
-$2,805,196.53
2.48M
Oct 4 - Dec 30
Form 4
—
0
$44.53
-$4,874,247.91
2.54M
Scheduled
Jun 7
Form 4
+0.08%
2.07K
—
—
2.54M
Jun 2
Form 4
-1.81%
-46.76K
$60.11
-$2,811,048.43
2.54M
Scheduled
May 21 - May 24
Form 4
-0.12%
-3.24K
$60.11
-$194,588.72
2.59M
Scheduled
May 3
Form 4
-1.89%
-50.00K
$56.62
-$2,831,070.88
2.59M
Scheduled
Apr 1
Form 4
-3.65%
-100.00K
$66.22
-$6,622,207.14
2.64M
Scheduled
Mar 1
Form 4
-12.74%
-400.00K
$26.10
-$10,440,000.00
2.74M
Jun 16
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
Jun 13
Form 4
+0.80%
25K
—
—
3.14M
Dec 12
Form 4
—
0
—
—
0
Dec 7
Form 3
—
0
—
—
0
No matching records found

Juno Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 12
Form 4
+233.33%
175K
—
—
250K
Dec 23
Form 3
—
0
—
—
0
No matching records found